All options are supplied as 10 vials per selected combination, supporting flexible experimental design, batch testing, and extended research programmes
This product is intended strictly for laboratory research and scientific investigation purposes only.The peptides and peptide blends are not approved for human or veterinary use
The Complete Research Protocol: BPC-157, TB-500 & Solvent
However, no assessments were carried out during the period of dosing that can provide relevant information
In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders
